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Two further RCTs (Koons et al., 1998; Linehan et al., in press) and two parallel comparison controlled trials (Rathus & Miller, 1999; Stanley, Ivanoff, Brodsky, & Oppenheim, 1998) investigating DBT versus TAU have been conducted. Koons et al. (1998) conducted a small study (N ϭ 20) in a Veterans' Administration clinic and reported outcomes after 6 months of weekly DBT compared to 6 months of TAU. (Therapists in the TAU condition described their orientation to individual therapy as cognitive-behavioral.) Participants were female veterans who met criteria for BPD but, differing from Linehan et al. (1991) , were not required to have had a history of parasuicide or a recent parasuicide. This resulted in a sample that was less parasuicidal and less frequently hospitalized than were those in the Linehan et al. (1991) study. Koons et al. found that those in DBT had greater reduction in suicidal ideation, depression, hopelessness, and anger than those in TAU at posttreatment. Those in DBT showed a trend toward significantly fewer psychiatric hospital admissions and inpatient days; however, both groups had low pretreatment frequency of hospitalization. Both treatment conditions had good treatment retention and both groups showed significant decreases in depression, with 60% of those in DBT and 20% of those in TAU showing clinically significant change on the Beck Depression Inventory (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) . Linehan et al. (in press ) have also reported outcomes from an RCT (N ϭ 28) comparing an adaptation of DBT for substance-dependent women with BPD to TAU. The major modifications to standard DBT were the addition of (1) specific targets relevant to drug use, (2) a set of attachment strategies intended to enhance the patient's connection to therapy and the treatment team, (3) a drugreplacement program, (4) three-times-weekly urinalyses, and (5) case management (Linehan & Dimeff, 1997) . Sub-Scheel (this issue) provides an excellent brief description of dialectical behavior therapy (DBT ; Linehan 1993a Linehan , 1993b and then summarizes and critiques the research evidence regarding DBT's efficacy. In addition to highlighting the limited evidence available at the time of her review, Scheel highlights the limitations of the treatment as usual (TAU) comparison design used in Linehan's first randomized clinical trial (RCT; Linehan, Armstrong, Suarez, Allmon, & Heard, 1991) and the subsequent reports from that sample (Linehan et al., 1991; Linehan, Heard, & Armstrong, 1993; Linehan, Tutek, Heard, & Armstrong, 1994) . Although the TAU design has benefits for early investigations of a treatment's efficacy (particularly with this population; Linehan, this issue), the lack of experimental control in a TAU design means that there are competing explanations for findings. Research that replicates Linehan's work is needed to evaluate the efficacy of DBT. Several studies have been conducted and reported in peer-reviewed contexts that were not included in Scheel's review, and we summarize here these further data on DBT's efficacy (see Koerner & Linehan, in press , for more detailed review).
R EC EN T R ES EA RC H NO T I NC LU DE D IN S CH EE L' S RE VI E W
DBT organizes standard cognitive-behavioral treatment strategies into protocols intended to guide interventions completion of treatment, subjects were review, and consultation team. 42%). DBT subjects had significantly fewer inpatient assessed at 6-month intervals for one Subjects were exposed to all skills hospital days compared to TAU subjects. These findings year.
twice within this 12-month trial. were largely maintained throughout the posttreatment follow-up year. During the one-year posttreatment followup, parasuicide repeat rate was significantly lower for DBT subjects compared to TAU (26% vs. 60%) Chronically suicidal women Subjects already in psychotherapy Linehan's original trial. Hence, all were no suicide attempts in either group during the skills were taught one time only.
duration of the study.
(continued) Miller et al. (1996) Suicidal teens (mean age ϭ
Nonrandomized control quasi-
Modifications to standard DBT Subjects in DBT group were significantly more likely to 16); outpatient services in experimental pilot study comparing included inclusion of as-needed complete treatment than were TAU subjects (62% vs. individual and family sessions. The DBT condition consisted of 12 weeks of twice weekly individual and multifamily skills training. Because of nonrandom assignment, the DBT group had lower socioeconomic status, was more ethnically diverse, and was more severely impaired than was the TAU group at pretreatment. Significant differences in psychiatric hospitalization (DBT 0%, TAU 13%) and treatment retention (DBT 62% completed, TAU 40%) were observed favoring DBT. No group differences were observed in the number of suicide attempts. However, given that the most suicidal and severe individuals (i.e., greater number of Axis I disorders and prior hospitalizations, more impulsivity) were assigned to DBT, this finding is noteworthy. These studies each found that individuals receiving DBT showed reductions in targeted problem areas when compared to TAU. In the more severely impaired populations of borderline personality disordered individuals, DBT reduced parasuicidal behavior and substance abuse, increased treatment retention, and improved global functioning at posttreatment and/or follow-up. With a less severe population of BPD patients, DBT appeared to produce specific improvements in suicidal ideation, depression, and hopelessness, even when compared to a TAU condition that also produces clinically significant changes in depression. The studies by Koons et al. (1998) , Stanley et al. (1998) , and Rathus and Miller (1999) suggest that the findings favoring DBT over TAU are replicable by independent investigators (i.e., are not unique to research conducted by Linehan, the treatment developer), that these outcomes can be obtained within naturalistic clinical settings, and that a 6-month treatment (or for adolescents perhaps even a 12-week treatment) may have efficacy.
These findings taken as a group increase confidence that effects are likely due to DBT, but the TAU comparison design does not allow sufficient experimental control for certain conclusions. For example, it is almost impossible to determine whether it is DBT itself that is responsible for treatment gains or simply well-organized psychotherapy. The question remains of whether the results are attributable to the efficacy of DBT or to any of a number of competing factors, including (1) therapist factors (expertise, training, or clinical experience), (2) availability of clinical supervision, (3) hours of individual psychotherapy offered, (4) general factors associated with receiving any psychotherapy, (5) institutional prestige jects meeting criteria for BPD as well as for polysubstance use disorder or substance use disorder for amphetamines, anxiolytics, cocaine, cannabis, hypnotics, opiates, or sedatives were randomly assigned to either DBT (n ϭ 12) or TAU (n ϭ 16) for a year of treatment. Subjects were assessed at 4, 8, 12 months and at a 16-month follow-up. Subjects assigned to DBT had significantly greater reductions in drug abuse measured by both structured interviews and urinalyses throughout the treatment year and at follow-up than did subjects assigned to TAU. There was a trend for DBT to have significantly higher retention (36% dropout in DBT, 73% dropout in TAU). There were no significant differences in amount of medical and psychiatric inpatient treatment received during the course of treatment. There were no significant differences in global and social adjustment and state and trait anger between the groups during treatment or at 12 months, but those in DBT showed significantly greater gains in global and social adjustment and state and trait anger at follow-up compared to those in TAU. Stanley et al. (1998) have recently presented further evidence on DBT as a treatment for suicidal BPD patients using matched controls rather than random assignment. They conducted a small pilot study (N ϭ 30) examining the efficacy of a 6-month treatment comparing DBT versus TAU. The baseline mean number of suicide attempts did not differ between the DBT and TAU groups. At follow-up, investigators found that patients in DBT had significantly greater reduction in self-mutilation acts, suicide ideation, suicidal urges, and urges to self-mutilate than did subjects who received TAU. Neither group had a suicide attempt. Rathus and Miller (1999) conducted a nonrandomized controlled pilot study to examine whether DBT for adolescents was more efficacious than TAU at reducing suicide attempts, reducing psychiatric hospitalization, and increasing treatment retention. Participants in the study were referrals (N ϭ 111) to an adolescent depression and suicide program in the Bronx (78% female). The most severe and suicidal participants were referred to the DBT condition (i.e., all individuals in DBT had made a suicide attempt within the last 16 weeks or had current suicide ideation). All participants met three or more criteria of borderline personality disorder as measured by the Structured Clinical Interview for DSM-IV Axis II Personality Disorders. TAU consisted of 12 weeks of twice weekly associated with receiving treatment in a university setting for the DBT condition, or (6) other factors associated with design flaws.
Linehan and colleagues recently reported preliminary findings from two further RCTs underway at the University of Washington. In these studies they evaluated the efficacy of DBT by using more rigorous experimental control conditions developed specifically to maximize internal validity and to control for effects on clinical outcomes by factors not controlled for in previous DBT studies. In a replication study treating individuals with BPD and parasuicidal behavior, DBT was compared with a more rigorous control condition, treatment by experts in the community (TBE). TBE therapists were nominated by community mental health leaders (i.e., heads of inpatient psychiatric units, clinical directors of mental health agencies, and training directors of psychiatry, psychology, social work, and nursing) as expert and experienced with BPD and suicidal patients (controlling for therapist expertise). TBE therapists were asked to provide the therapy they believed most suited to the patient they were treating, and the content of the treatment they provided was not interfered with or controlled by the research study (controlling for therapist allegiance to treatment provided). Clinical supervision was provided to TBE therapists by a well-respected expert supervisor (therapists were paid to attend, controlling for the availability of clinical supervision). As with the DBT consultation team function, the purpose of supervision was to assist therapists in doing psychotherapy to the best of their abilities, to provide an opportunity for therapists to get support from their peers, and to be on call for therapists in emergencies. The TBE condition was associated with an institution committed to excellence (Seattle Institute for Psychoanalysis, controlling for institutional prestige associated with therapy offered). The study paid (at the same rate of pay) for psychotherapy in both conditions, and subjects were required to pay only a small amount on a sliding fee (controlling for availability of affordable treatment and for hours of individual psychotherapy offered). TBE therapists were matched on treatment-relevant variables (controlling for therapist gender, training, and clinical experience).
In their report on preliminary data from 4-month assessments of this more rigorous replication design, found promising results favoring DBT. Compared to a treatment by experts in the community control condition designed to maximize internal validity, those individuals receiving DBT showed greater reduction in suicidal behaviors, increases in treatment retention, and reduction of use of inpatient psychiatric care and emergency services.
Linehan and colleagues have also replicated DBT for individuals with BPD and opiate addiction in a second RCT with a more rigorous control condition . In this "dismantling" study, a component control treatment, DBT-validation (DBT-V), was used to examine which components of DBT are necessary for change. The rationale for DBT-V is based on the work of William Swann as interpreted by Linehan (1997) for treatment of drug abusers. The rationale suggests that emotion dysregulation (and, by extension, BPD) is related to previous experiences in invalidating environments that inhibit the individual's natural responses to situations and teach the individual to invalidate his or her own natural responses. This inability to self-validate precipitates extreme emotional arousal and a sense of loss of control when important people invalidate the individual. Clinical progress requires the therapist's use of validation procedures, communicating to the patient that she can trust herself, and reinforcing selfverification even when the environment is invalidating. In this control condition, the only focus on patient change concerns patient's attendance at psychotherapy, Narcotics Anonymous meetings, and meetings with sponsors. Preliminary findings from this outcome study suggest that validation strategies may be powerful when working with substance-dependent women with BPD. All participants were retained for the entire duration of the 12-month treatment in DBT-V; 64% were retained in DBT. Both treatments performed comparably, as measured by selfreport and thrice weekly urinalyses, in reducing substance abuse over time. By the completion of treatment, 68% of participants in DBT reported abstaining from drug use in the prior month compared to 55% in DBT-V. Rates of abstinence held through 16 months for DBT and increased to 65% abstinent in DBT-V.
Further data are also available regarding the efficacy of DBT within an inpatient setting. Bohus, Haaf, and Stiglmayr (in press ) reported pre-post data for an inpatient DBT protocol. Study participants were 24 female patients who met criteria for BPD according to Diagnostic Inter-In a recently published study, Evans et al. (1999) reported data from a randomized controlled trial (N ϭ 34) comparing a manual-assisted cognitive-behavioral brief intervention (MACT) to TAU. MACT is a problemfocused psychotherapy (problem-solving and basic cognitive techniques to manage emotions and prevent relapse) with accompanying brief bibliotherapy. MACT incorporated the behavioral chain analysis of parasuicide episodes as well as a subset of skills from the DBT distress tolerance module. Patients were included in the study if they had a recent episode of deliberate self-harm and at least one other episode of parasuicide in the last year as well as a cluster B personality disorder. Exposure to MACT ranged from two to six sessions. During the 6-month assessment period, 10 subjects (56% MACT, 71% TAU) engaged in parasuicidal behavior. The rate of parasuicidal acts per month was lower with MACT than in TAU (median 0.17/month vs. 0.37/month, respectively). This finding was not statistically significant ( p ϭ 0.11), which may be due to lack of statistical power. A statistically significant difference between conditions was noted on self-report of depression favoring MACT. The observed average cost of care was 46% less with MACT.
C ON CL US IO NS
Preliminary findings from more rigorously controlled studies suggest that the earlier findings of treatment effects for DBT versus TAU are likely robust and due to DBT and not to other factors. As further data have become available, it appears not only that DBT benefits individuals with chronic suicidal behavior and BPD, but perhaps also that DBT may also be usefully adapted to other disorders in which dysfunctional behaviors serve to regulate emotion such as substance abuse and binge eating disorder.
Scheel suggests that DBT may be difficult to implement within typical community mental health settings, but on the contrary, it may be that DBT can be implemented in an exemplary manner. For example, the American Psychiatric Association awarded the Community Mental Health Center of Greater Manchester in New Hampshire the 1998 Gold Achievement Award for the excellence of their small community-based DBT program (Mental Health Center of Greater Manchester, 1998). DBT may be cost-effective and resource-effective in a community mental health setting. Further, despite the multifaceted combination of treatment strategies in DBT, there is evidence that mental health professionals outside view for Borderline-Revised (Zanarini, Gunderson, Frankenburg, & Chauncey, 1989) and Diagnostic and Statistical Manual for Mental Disorders (4th ed.; American Psychiatric Association, 1995) and who had at least two parasuicide acts within the past two years. Patients were excluded if they met criteria for schizophrenia, bipolar I disorders, or alcohol or drug dependence (current or within the last 6 months), or if suicide attempts or selfinjurious behavior occurred only during major depressive disorder episode or under influence of alcohol or drugs. Patients were assessed at admission to the hospital, at discharge, and at one month after discharge on frequency of parasuicide and psychopathology. They found a significant decrease in number of parasuicidal acts and significant improvements in ratings of depression, dissociation, anxiety, and global stress. The reported effect sizes were strong and indicate that BPD patients not only did not decompensate in inpatient DBT but also may perhaps show some benefit.
Two other studies have investigated adaptations or modifications of components of DBT. Telch, Agras, and Linehan (1999) have reported preliminary pilot data on DBT adapted to treatment of binge eating disorder. The adaptation was based on the theoretical model that binge eating functions as affect regulation and, therefore, that teaching adaptive emotion regulation skills will eliminate maladaptive emotion regulation behaviors. Telch developed a 20-session group format that modified DBT to binge eating problems by tailoring the treatment target hierarchy and creating experiential exercises to teach and strengthen skills (e.g., mindful eating exercises). Telch also made the treatment distinct from interpersonal psychotherapy (by removing the interpersonal effectiveness module) and distinct from standard cognitive-behavioral therapy for eating disorders (i.e., standard cognitivebehavioral therapy components such as self-monitoring of food intake, prescriptions for normalization of eating and meal patterning, and cognitive restructuring of weight and shape concerns were not included). Data from a small (N ϭ 11) pre-post design are very promising: both the number of binge episodes and the number of binge days decreased significantly from baseline to posttreatment, and participants also lost weight. At 3-and 6-months posttreatment, participants showed strong continued abstinence from binge eating and maintenance of lower weight. Telch et al. (1999) report having no dropout from treatment and good attendance at group sessions. of academic research centers can learn DBT quite effectively (Hawkins & Singha, 1998) . Another strength of the data on DBT is that the patient population studied is similar to those served by community mental health services. In addition to meeting criteria for BPD, participants in studies on DBT have had high rates of comorbid mood and anxiety disorder, substance abuse, eating disorders, and other Axis II disorders.
Although data for DBT are stronger than Scheel's review suggests, we share Scheel's concern that adoption and dissemination of new treatments be guided by data. Toward that end, our own efforts to train researchers and clinicians have purposely tried to maximize factors we think will result in programmatic implementations at a high level of treatment integrity. For example, we encourage trainees to first implement the standard treatment with as much fidelity as possible, rather than in part or piecemeal. We further require trainees to develop plans to evaluate the effectiveness of the approach in their own practice setting as part of the training in the new treatment approach. The rigor and integrity of the training model will strongly determine the quality of implementation. Further development and evaluation of dissemination models that result in high-quality implementation are needed.
